Click here to get full coverage on Achieve Life Sciences, Inc. $ACHV Shares Sold by Clearline Capital LP - MarketBeat

Achieve Life Sciences, Inc. $ACHV Shares Sold by Clearline Capital LP  MarketBeat

Achieve Life Sciences, Inc. $ACHV Shares Sold by Clearline Capital LP - MarketBeat

Click here to get full coverage on Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near Future - Yahoo Finance

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near Future  Yahoo Finance

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near Future - Yahoo Finance

Click here to get full coverage on Achieve Life Sciences (ACHV) Announces $300M Securities Shelf Re - GuruFocus

Achieve Life Sciences (ACHV) Announces $300M Securities Shelf Re  GuruFocus

Achieve Life Sciences (ACHV) Announces $300M Securities Shelf Re - GuruFocus

Click here to get full coverage on New study: smokers who failed other quit drugs stop with cytisinicline - Stock Titan

New study: smokers who failed other quit drugs stop with cytisinicline  Stock Titan

New study: smokers who failed other quit drugs stop with cytisinicline - Stock Titan

Click here to get full coverage on Achieve Life Sciences Stock (ACHV) Opinions on FDA Priority Voucher Award - Quiver Quantitative

Achieve Life Sciences Stock (ACHV) Opinions on FDA Priority Voucher Award  Quiver Quantitative

Achieve Life Sciences Stock (ACHV) Opinions on FDA Priority Voucher Award - Quiver Quantitative

Click here to get full coverage on Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch - Seeking Alpha

Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch  Seeking Alpha

Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch - Seeking Alpha

Click here to get full coverage on Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving Average - Time to Sell? - MarketBeat

Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving Average - Time to Sell?  MarketBeat

Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving Average - Time to Sell? - MarketBeat

Click here to get full coverage on “Put it in the water!” — How a Toxic Tree May Save Thousands of Smokers - Hunterbrook

“Put it in the water!” — How a Toxic Tree May Save Thousands of Smokers  Hunterbrook

“Put it in the water!” — How a Toxic Tree May Save Thousands of Smokers - Hunterbrook

Click here to get full coverage on Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory - Yahoo Finance

Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory  Yahoo Finance

Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on Achieve Life Sciences (NASDAQ: ACHV) among nine awarded FDA voucher for vaping cessation - Stock Titan

Achieve Life Sciences (NASDAQ: ACHV) among nine awarded FDA voucher for vaping cessation  Stock Titan

Achieve Life Sciences (NASDAQ: ACHV) among nine awarded FDA voucher for vaping cessation - Stock Titan

Click here to get full coverage on New Analyst Forecast: $ACHV Given $19.0 Price Target | ACHV Stock News - Quiver Quantitative

New Analyst Forecast: $ACHV Given $19.0 Price Target | ACHV Stock News  Quiver Quantitative

New Analyst Forecast: $ACHV Given $19.0 Price Target | ACHV Stock News - Quiver Quantitative

Click here to get full coverage on FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation - Yahoo Finance

FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation  Yahoo Finance

FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation - Yahoo Finance

Click here to get full coverage on Five new hires at Achieve Life Sciences get 115,000 stock options - Stock Titan

Five new hires at Achieve Life Sciences get 115,000 stock options  Stock Titan

Five new hires at Achieve Life Sciences get 115,000 stock options - Stock Titan

Click here to get full coverage on Achieve Life Sciences, Inc. $ACHV Shares Sold by Propel Bio Management LLC - MarketBeat

Achieve Life Sciences, Inc. $ACHV Shares Sold by Propel Bio Management LLC  MarketBeat

Achieve Life Sciences, Inc. $ACHV Shares Sold by Propel Bio Management LLC - MarketBeat

Click here to get full coverage on Should You Hold Achieve Life Sciences (ACHV)? - Yahoo Finance

Should You Hold Achieve Life Sciences (ACHV)?  Yahoo Finance

Should You Hold Achieve Life Sciences (ACHV)? - Yahoo Finance

Click here to get full coverage on When Will Achieve Life Sciences, Inc. (NASDAQ:ACHV) Turn A Profit? - Yahoo Finance

When Will Achieve Life Sciences, Inc. (NASDAQ:ACHV) Turn A Profit?  Yahoo Finance

When Will Achieve Life Sciences, Inc. (NASDAQ:ACHV) Turn A Profit? - Yahoo Finance

Click here to get full coverage on ACHV: FDA’s CNPV Awarded for Vaping - Yahoo Finance

ACHV: FDA’s CNPV Awarded for Vaping  Yahoo Finance

ACHV: FDA’s CNPV Awarded for Vaping - Yahoo Finance

Click here to get full coverage on ACHV: Preparations Continue as PDUFA Date Assigned - Yahoo Finance

ACHV: Preparations Continue as PDUFA Date Assigned  Yahoo Finance

ACHV: Preparations Continue as PDUFA Date Assigned - Yahoo Finance

Click here to get full coverage on Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Expedites Review of Vaping Cessation Therapy - What's Changed - Yahoo Finance

Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Expedites Review of Vaping Cessation Therapy - What's Changed  Yahoo Finance

Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Expedites Review of Vaping Cessation Therapy - What's Changed - Yahoo Finance

Click here to get full coverage on H.C. Wainwright Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛

H.C. Wainwright Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $12  富途牛牛

H.C. Wainwright Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛

Click here to get full coverage on Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Recommendation of "Moderate Buy" from Brokerages  MarketBeat

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Click here to get full coverage on Achieve Life Sciences (Nasdaq: ACHV) grants 250,000 stock options to new CLO - Stock Titan

Achieve Life Sciences (Nasdaq: ACHV) grants 250,000 stock options to new CLO  Stock Titan

Achieve Life Sciences (Nasdaq: ACHV) grants 250,000 stock options to new CLO - Stock Titan

Click here to get full coverage on Recent uptick might appease Achieve Life Sciences, Inc. (NASDAQ:ACHV) institutional owners after losing 33% over the past year - simplywall.st

Recent uptick might appease Achieve Life Sciences, Inc. (NASDAQ:ACHV) institutional owners after losing 33% over the past year  simplywall.st

Recent uptick might appease Achieve Life Sciences, Inc. (NASDAQ:ACHV) institutional owners after losing 33% over the past year - simplywall.st

Click here to get full coverage on Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Awards Rare Priority Voucher for Vaping Cessation Drug – Has the Bull Case Changed? - simplywall.st

Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Awards Rare Priority Voucher for Vaping Cessation Drug – Has the Bull Case Changed?  simplywall.st

Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Awards Rare Priority Voucher for Vaping Cessation Drug – Has the Bull Case Changed? - simplywall.st

Click here to get full coverage on Achieve (NASDAQ: ACHV) completes ORCA-OL; 334 one-year participants exceed FDA request - Stock Titan

Achieve (NASDAQ: ACHV) completes ORCA-OL; 334 one-year participants exceed FDA request  Stock Titan

Achieve (NASDAQ: ACHV) completes ORCA-OL; 334 one-year participants exceed FDA request - Stock Titan

Click here to get full coverage on Achieve Life Sciences Receives FDA National Priority Voucher | ACHV Stock News - Stock Titan

Achieve Life Sciences Receives FDA National Priority Voucher | ACHV Stock News  Stock Titan

Achieve Life Sciences Receives FDA National Priority Voucher | ACHV Stock News - Stock Titan

Click here to get full coverage on ACHV: Achieve’s Busy Day - Yahoo Finance

ACHV: Achieve’s Busy Day  Yahoo Finance

ACHV: Achieve’s Busy Day - Yahoo Finance

Click here to get full coverage on Achieve Life Sciences (NASDAQ:ACHV) Shares Pass Above 200 Day Moving Average - What's Next? - MarketBeat

Achieve Life Sciences (NASDAQ:ACHV) Shares Pass Above 200 Day Moving Average - What's Next?  MarketBeat

Achieve Life Sciences (NASDAQ:ACHV) Shares Pass Above 200 Day Moving Average - What's Next? - MarketBeat

Click here to get full coverage on Nicotine addiction expert takes lead medical role at Achieve Life Sciences - Stock Titan

Nicotine addiction expert takes lead medical role at Achieve Life Sciences  Stock Titan

Nicotine addiction expert takes lead medical role at Achieve Life Sciences - Stock Titan

Click here to get full coverage on A Look at Achieve Life Sciences's Valuation After Rare FDA Priority Voucher for Nicotine Vaping Therapy - simplywall.st

A Look at Achieve Life Sciences's Valuation After Rare FDA Priority Voucher for Nicotine Vaping Therapy  simplywall.st

A Look at Achieve Life Sciences's Valuation After Rare FDA Priority Voucher for Nicotine Vaping Therapy - simplywall.st

Click here to get full coverage on First New Smoking Cessation Drug in Two Decades: FDA to Review Achieve's Cytisinicline Treatment - Stock Titan

First New Smoking Cessation Drug in Two Decades: FDA to Review Achieve's Cytisinicline Treatment  Stock Titan

First New Smoking Cessation Drug in Two Decades: FDA to Review Achieve's Cytisinicline Treatment - Stock Titan

Click here to get full coverage on Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200 Day Moving Average - What's Next? - MarketBeat

Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200 Day Moving Average - What's Next?  MarketBeat

Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200 Day Moving Average - What's Next? - MarketBeat

Click here to get full coverage on Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week - PR Newswire

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week  PR Newswire

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week - PR Newswire

Click here to get full coverage on Achieve: Expedited Review Of Cytisinicline Sets Stage For Development Expansion (ACHV) - Seeking Alpha

Achieve: Expedited Review Of Cytisinicline Sets Stage For Development Expansion (ACHV)  Seeking Alpha

Achieve: Expedited Review Of Cytisinicline Sets Stage For Development Expansion (ACHV) - Seeking Alpha

Click here to get full coverage on Citizens initiates Achieve Life Sciences stock with Market Outperform rating - Investing.com

Citizens initiates Achieve Life Sciences stock with Market Outperform rating  Investing.com

Citizens initiates Achieve Life Sciences stock with Market Outperform rating - Investing.com

Click here to get full coverage on Achieve Life Sciences: Promising Pipeline But High Risks Makes Me Hold For Now (NASDAQ:ACHV) - Seeking Alpha

Achieve Life Sciences: Promising Pipeline But High Risks Makes Me Hold For Now (NASDAQ:ACHV)  Seeking Alpha

Achieve Life Sciences: Promising Pipeline But High Risks Makes Me Hold For Now (NASDAQ:ACHV) - Seeking Alpha

Click here to get full coverage on Achieve Life Sciences stock soars after receiving FDA priority voucher - Investing.com

Achieve Life Sciences stock soars after receiving FDA priority voucher  Investing.com

Achieve Life Sciences stock soars after receiving FDA priority voucher - Investing.com

Click here to get full coverage on Achieve Life Sciences (ACHV) Gains on Promising Cytisinicline An - GuruFocus

Achieve Life Sciences (ACHV) Gains on Promising Cytisinicline An  GuruFocus

Achieve Life Sciences (ACHV) Gains on Promising Cytisinicline An - GuruFocus

Click here to get full coverage on Achieve Life Sciences (ACHV) Identified as Top Biopharma Prospec - GuruFocus

Achieve Life Sciences (ACHV) Identified as Top Biopharma Prospec  GuruFocus

Achieve Life Sciences (ACHV) Identified as Top Biopharma Prospec - GuruFocus

Click here to get full coverage on Raymond James reiterates Strong Buy on Achieve Life Sciences stock - Investing.com

Raymond James reiterates Strong Buy on Achieve Life Sciences stock  Investing.com

Raymond James reiterates Strong Buy on Achieve Life Sciences stock - Investing.com

Click here to get full coverage on Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years - Yahoo Finance

Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years  Yahoo Finance

Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years - Yahoo Finance

Click here to get full coverage on Achieve Life Sciences (ACHV) Stock Plummets Amid Marketing Plans with Omnicom - GuruFocus

Achieve Life Sciences (ACHV) Stock Plummets Amid Marketing Plans with Omnicom  GuruFocus

Achieve Life Sciences (ACHV) Stock Plummets Amid Marketing Plans with Omnicom - GuruFocus

Click here to get full coverage on Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk (ACHV) - Seeking Alpha

Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk (ACHV)  Seeking Alpha

Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk (ACHV) - Seeking Alpha

Click here to get full coverage on Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation - Seeking Alpha

Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation  Seeking Alpha

Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation - Seeking Alpha

Click here to get full coverage on ACHV Secures FDA Priority Voucher for Novel Vaping Cessation The - GuruFocus

ACHV Secures FDA Priority Voucher for Novel Vaping Cessation The  GuruFocus

ACHV Secures FDA Priority Voucher for Novel Vaping Cessation The - GuruFocus

Click here to get full coverage on Achieve Life Sciences (ACHV) Appoints New Chief Medical Officer - GuruFocus

Achieve Life Sciences (ACHV) Appoints New Chief Medical Officer  GuruFocus

Achieve Life Sciences (ACHV) Appoints New Chief Medical Officer - GuruFocus

Click here to get full coverage on Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program - Yahoo Finance

Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program  Yahoo Finance

Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program - Yahoo Finance

Click here to get full coverage on H.C. Wainwright reiterates Buy rating on Achieve Life Sciences stock - Investing.com

H.C. Wainwright reiterates Buy rating on Achieve Life Sciences stock  Investing.com

H.C. Wainwright reiterates Buy rating on Achieve Life Sciences stock - Investing.com

Click here to get full coverage on Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory - Insider Monkey

Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory  Insider Monkey

Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory - Insider Monkey

Click here to get full coverage on Achieve Life Sciences Receives FDA's First National Priority Voucher for Cytisinicline in Vaping Cessation Treatment - Quiver Quantitative

Achieve Life Sciences Receives FDA's First National Priority Voucher for Cytisinicline in Vaping Cessation Treatment  Quiver Quantitative

Achieve Life Sciences Receives FDA's First National Priority Voucher for Cytisinicline in Vaping Cessation Treatment - Quiver Quantitative

Click here to get full coverage on A Look at Achieve Life Sciences's Valuation After FDA Priority Voucher for Cytisinicline Therapy - Yahoo Finance

A Look at Achieve Life Sciences's Valuation After FDA Priority Voucher for Cytisinicline Therapy  Yahoo Finance

A Look at Achieve Life Sciences's Valuation After FDA Priority Voucher for Cytisinicline Therapy - Yahoo Finance

Click here to get full coverage on Achieve Life Sciences jumps on Hunterbrook Capital endorsement - Seeking Alpha

Achieve Life Sciences jumps on Hunterbrook Capital endorsement  Seeking Alpha

Achieve Life Sciences jumps on Hunterbrook Capital endorsement - Seeking Alpha

Click here to get full coverage on Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy - Seeking Alpha

Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy  Seeking Alpha

Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy - Seeking Alpha

Click here to get full coverage on Achieve Life Sciences (ACHV) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

Achieve Life Sciences (ACHV) FDA Approvals, PDUFA Dates & Drug Alerts 2026  MarketBeat

Achieve Life Sciences (ACHV) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

Click here to get full coverage on Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program - GlobeNewswire

Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program  GlobeNewswire

Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program - GlobeNewswire

Click here to get full coverage on Achieve Life Sciences appoints Mark Rubinstein as permanent CMO - Investing.com

Achieve Life Sciences appoints Mark Rubinstein as permanent CMO  Investing.com

Achieve Life Sciences appoints Mark Rubinstein as permanent CMO - Investing.com

Click here to get full coverage on Achieve Life Sciences appoints Erik Atkisson as chief legal officer - Investing.com

Achieve Life Sciences appoints Erik Atkisson as chief legal officer  Investing.com

Achieve Life Sciences appoints Erik Atkisson as chief legal officer - Investing.com

Click here to get full coverage on Achieve Life Sciences Announced Granting of New Hire Inducement Awards - GlobeNewswire

Achieve Life Sciences Announced Granting of New Hire Inducement Awards  GlobeNewswire

Achieve Life Sciences Announced Granting of New Hire Inducement Awards - GlobeNewswire

Click here to get full coverage on Raymond James Predicts Up to ~760% Surge for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Raymond James Predicts Up to ~760% Surge for These 2 ‘Strong Buy’ Stocks  Yahoo Finance

Raymond James Predicts Up to ~760% Surge for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Click here to get full coverage on Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer - GlobeNewswire

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer  GlobeNewswire

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer - GlobeNewswire

Click here to get full coverage on ACHV Surge: Betting on the Future? - StocksToTrade

ACHV Surge: Betting on the Future?  StocksToTrade

ACHV Surge: Betting on the Future? - StocksToTrade

Click here to get full coverage on Earnings call transcript: Achieve Life Sciences Q3 2025 sees earnings miss, stock rises - Investing.com

Earnings call transcript: Achieve Life Sciences Q3 2025 sees earnings miss, stock rises  Investing.com

Earnings call transcript: Achieve Life Sciences Q3 2025 sees earnings miss, stock rises - Investing.com

Click here to get full coverage on Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket - Benzinga

Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket  Benzinga

Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket - Benzinga

Click here to get full coverage on 4 Biotech Stocks Lifting Off As Momentum Builds - Rani Therapeutics Hldgs (NASDAQ:RANI) - Benzinga

4 Biotech Stocks Lifting Off As Momentum Builds - Rani Therapeutics Hldgs (NASDAQ:RANI)  Benzinga

4 Biotech Stocks Lifting Off As Momentum Builds - Rani Therapeutics Hldgs (NASDAQ:RANI) - Benzinga

Click here to get full coverage on Achieve Life Sciences Announces Proposed Underwritten Public Off - GuruFocus

Achieve Life Sciences Announces Proposed Underwritten Public Off  GuruFocus

Achieve Life Sciences Announces Proposed Underwritten Public Off - GuruFocus

Click here to get full coverage on Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...  Yahoo Finance

Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Click here to get full coverage on ACHV: Commercialization in Focus - Zacks Small Cap Research

ACHV: Commercialization in Focus  Zacks Small Cap Research

ACHV

Price Chart

Key Statistics

Technicals

About ACHV

Latest News

Achieve Life Sciences, Inc. $ACHV Shares Sold by Clearline Capital LP - MarketBeat

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near Future - Yahoo Finance

Achieve Life Sciences (ACHV) Announces $300M Securities Shelf Re - GuruFocus

Advanced Charts

Top Gainers

Top Losers